Please login to the form below

Memorial Sloan Kettering

This page shows the latest Memorial Sloan Kettering news and features for those working in and with pharma, biotech and healthcare.

BCMA in the spotlight as ASH abstracts drop

GenScript Biotech, Poseida Therapeutics, CARsgen Therapeutics and Memorial Sloan Kettering Cancer Centre showing impressive efficacy results in multiple myeloma.

Latest news

Armoured CAR ‘could overwhelm solid tumour resistance’

Memorial Sloan Kettering Cancer Center's Renier Brentiens. The team, led by Renier Brentjens of Memorial Sloan Kettering Cancer Center in the US, modified CAR-T cells designed to seek out ... Eureka and Memorial Sloan Kettering have been working together
US insurers can peg access to ICER value reviews

Earlier this week, US industry body the Pharmaceutical Research and Manufacturers of America (PhRMA) highlighted a study by Memorial Sloan Kettering Cancer Center researchers in a blog post, which “reinforces that
Boehringer builds in immuno-oncology with €1.1bn-plus OSE deal

For OSE, the deal gives it another partnership with a large pharma partner, adding to collaborations with Memorial Sloan Kettering Cancer Centre in the US and biotech Selexis on immuno-oncology,
Gilead adds to CAR-T assets with Cell Design Labs buyout

It’s an exciting time, ”said Renier Brentjens, medical oncologist and director of cellular therapeutics at Memorial Sloan Kettering Cancer Centre.
Keytruda claims first blood cancer OK from FDA

fight against this devastating disease," said Craig Moskowitz, clinical director of the division of haematologic oncology, Memorial Sloan Kettering Cancer Centre in the US.

More from news
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest Intelligence

Deal Watch September 2016

No other financial details were disclosed. Fate Therapeutics entered a three year arrangement with Memorial Sloan Kettering Cancer Center to use engineered pluripotent cell lines to develop T cell product candidates.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

Lilly appoints Maura Dickler as VP of late phase oncology development

She will join the pharma firm from the Memorial Sloan Kettering Cancer Center. ... She will move to the pharmaceutical company from the prestigious Memorial Sloan Kettering Cancer Center, where she currently serves as associate member, Breast Medicine
José Baselga joins BMS’ board of directors

Dr Baselga is currently the physician in chief at Memorial Sloan Kettering Cancer Center, where he is responsible for the management of patients care, enhancing and expanding programmes in clinical and
OncoMed’s CMO steps down

Prior to this, Dr Dupont was director of early and late stage development at Genentech, and served as a researcher in tumour immunology at the Memorial Sloan Kettering Cancer Center.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

Getting personal with wearable tech

In July 2016, a prestigious US cancer centre, The Memorial Sloan Kettering Cancer Center (MSK), announced their plans to evaluate wearables and other mobile technology to assess cancer patients' quality of

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

New Business Director - PR: Competitive Salary and benefits

Client Services Director – Medical Education Agency – North West...: Salary TBC

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Senior Systematic Review Analyst - Oxford: Negotiable

Consultant Health Economics - London / Oxford: Negotiable

Project / Account Manager (Medical Education): Salary TBC

Associate Director: £75, 000-90, 000

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Medical Writer: Competitive Salary

Senior Medical Writer: Great salary and benefits

Account Director: £48, 000 - £60, 000

Senior Account Manager > Account Director - London - Medical ...: Salary TBC

Account Manager / Senior Account Manager: 35, 000-40, 000

Medical Writers Required – Cheshire: DOE

Production Manager – Healthcare Communications: DOE

Digital Manager, London – Healthcare Brandcomms, Medcomms, PR: Excellent package

Scientific Director / Editorial Team Leader: Great salary and benefits

Senior Medical Writer (Remote Working): Competitive Salary Offered

Associate Medical Director: Highly Competitive

Senior Account Executive, London, Medical Communications: Excellent package

Senior Account Director development role to Business Director, H...: Excellent package

Director, Market Access / HEOR - North-West: Negotiable

Subscribe to our email news alerts

PMHub

Add my company

Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...